AKT1 and Alzheimer disease: Neuronal loss and impaired survival signaling are central pathological features of AD, with accumulating evidence indicating that disruptions in PI3K–AKT, JAK–STAT, and MAPK pathways contribute significantly to synaptic degeneration, oxidative injury, and apoptosis [41,42,43,44].